Renata Weber, MD
Surgery of the Hand · Rutherford, NJNPI 1790855815
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (52.8%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. Axogen accounts for 76.7% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2019 at $7,599 and has fallen 95.3% since, to $356 in 2025.
Across 42 payments — averaging $225.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axogen$7K
- KCI USA, Inc.$940
- Integra Lifesciences Corporation$291
- AbbVie$215
- Sonex Health, Inc.$212
- Checkpoint Surgical, Inc$163
- plus $391 from 6 others
Across 17 payments — averaging $884.35 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Axogen$15K
What the payments were for
- Consulting fees$8008%
- Speaking & faculty fees$5,00053%
- Travel & lodging$7578%
- Food & beverage$2,92131%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axogen | 22 | $7,265 |
| KCI USA, Inc. | 2 | $940 |
| Integra Lifesciences Corporation | 4 | $291 |
| AbbVie(2 entities) | 2 | $215 |
| Sonex Health, Inc. | 2 | $212 |
| Checkpoint Surgical, Inc | 3 | $163 |
| Johnson & Johnson | 1 | $124 |
| Exsomed Corporation | 1 | $117 |
| Si-bone, Inc. | 1 | $60 |
| Davol Inc. | 1 | $50 |
| Endo Pharmaceuticals Inc. | 2 | $27 |
| Kerecis Limited | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AxoGuard Nerve Protector$6,407
- AxoGuard Nerve Connector$6,407
- INTEGRA$451
- AVANCE NERVE GRAFT$344
- INnate Implant$233
- INTEGRA DERMAL REGENERATION TEMPLATE$150
- PRIMATRIX$150
- NATRELLE$140
- PREVENA$140
- ULTRAGUIDECTR$126
- ULTRAGUIDETFR$126
- VISTASEAL$124
- MONOCRYL$124
- STRATAFIX$124
- DERMABOND PRINEO$124
- EVARREST$124
- InFrame Implant$117
- ArrowPhix System$117
- ArcPhix System$117
How this compares
Too few surgery of the hand providers in New Jerseyto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 15 | $6,361 |
| Diphenhydramine Hcl | 11 | $1,532 |
Paid to pharmacies, not to this prescriber.
Other surgery of the hand in Rutherford
- Ajul ShahPennington$104K
- Eric StraussVoorhees$9K
- Gary BreslowParamus$7K
- Stephen DudickGalloway$6K
- David TsaiPennington$5K
- Jeffry JacobsOradell$4K
- Oren MichaeliEnglewood$4K
- Steven UgrasParamus$2K
- Caroline McLaughlinCamden$2K
- Abram KirschenbaumDenville$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.